People: Orthofix International NV (OFIX.OQ)
Mr. Michael M. Finegan is Chief Strategy Officer of Orthofix International N.V., effective June 20, 2013. Mr. Finegan joined Orthofix International N.V. in June 2006 as Vice President of Corporate Development, and became the President, Biologics in March 2009. In October 2011, he was promoted to Senior Vice President, Business Development, and President, Biologics, and in June 2013, to his current position as Chief Strategy Officer. Prior to joining Orthofix, Mr. Finegan spent sixteen years as an executive with Boston Scientific in a number of different operating and strategic roles, most recently as Vice President of Corporate Sales. Earlier in his career, Mr. Finegan held sales and marketing roles with Marion Laboratories and spent three years in banking with First Union Corporation (Wachovia). Mr. Finegan earned a BA in Economics from Wake Forest University.
|Total Annual Compensation, USD||814,002|
|Restricted Stock Awards, USD||402,375|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||150,887|
|Fiscal Year Total, USD||1,367,260|